Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 03, 2020
Applied Photophysics has its Board of Directors has appointed Tim Flanagan as Chief Executive Officer and member of the Board of Directors effective immediately.
read more
Applied Photophysics and Fluorescence Innovations have entered into a joint venture agreement to develop and produce protein stability systems for researchers and industries globally.
read more
Applied StemCell has joined the National Institute of Standards and Technology (NIST) Genome Editing Consortium.
read more
Monday, November 06, 2017
Applied StemCell has received certifications for two ISO QMS on October 20, 2017, the ISO 9001:2015 and 13485:2016.
read more
Tuesday, December 22, 2020
Aprecia is partnering with Battelle to accelerate and expand its advanced capabilities in 3DP pharmaceutical manufacturing.
read more
Aprecia and CMIC CMO announced both companies will collaborate to develop business opportunities in Japan for Aprecia's ZipDose® Technology.
read more
Friday, February 21, 2020
Purdue University's College of Pharmacy and Aprecia Pharmaceuticals are launching a comprehensive collaboration on future 3DP pharmaceutical equipment and medications.
read more
Aptamer Group Ltd, the developer of custom affinity tools to enable the life science industry through its proprietary Optimer platform, and Bio-Works Technologies AB, the developer and manufacturer of leading-edge agarose-based purification ...
read more
Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, announced that it has signed an agreement with the multinational pharmaceutical and biopharmaceutical company Takeda Pharmaceutical Company Limited (“Takeda”).
read more
Wednesday, September 03, 2025
Aptamer Group ,a developer of synthetic binders for the life science industry, announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to ...
read more
Thursday, August 28, 2025
Aptamer Group announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to identify and validate new disease markers.
read more
Thursday, December 14, 2023
Aptamer Group plc, renowned for pioneering Optimer® binders that drive innovation in the life sciences sector, has formalized a substantial agreement with a biotechnology company specializing in genetic medicines.
read more
Aptamer Group announced a commercial partnership with Mologic, a developer and manufacturer of lateral flow and rapid diagnostic tests.
read more
Aptamer Group, developer of Optimer™ reagents and therapeutics, has announced the extension of their current agreement with AstraZeneca, a global biopharmaceutical company.
read more
Friday, November 01, 2019
AptarGroup has acquired drug delivery training devices and patient onboarding company Noble International.
read more